ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Also in this 8-page issue: FISH assay predicts survival on Iressa, Univ. of Colorado Cancer Center study finds.

May 6, 2005

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

NCI News: Communications Office Seeks Partners for Education Programs

October 11, 1996

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987